Predicting who will develop cancer: Role of biopsy, flow cytometry, cell and genetic markers

Gastrointestinal Endoscopy

Volumn 49, Issue 3 II, 1999, Pages

  Weinstein, W M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; CLINICAL PRACTICE; CONFERENCE PAPER; CYTOMETRY; DISEASE ASSOCIATION; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; GENETIC MARKER; HUMAN; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033032167     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(99)70517-1     Document Type: Conference Paper

References (18)

1. DJ Drewitz RE Sampliner HS Garewal The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years Am J Gastroenterol 92 2 1997 212 215
2. DA Lieberman M Oehlke M Helfand Risk factors for Barrett's esophagus in community-based practice Am J Gastroenterol 92 8 1997 1293 1297
3. GM Eisen RS Sandler S Murray M Gottfried The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus Am J Gastroenterol 92 l 1997 27 31
4. BJ Reid RC Haggitt CE Rubin Observer variation in the diagnosis of dysplasia in Barrett's esophagus Hum Pathol 19 2 1988 166 178
5. RH Riddell H Goldman DF Ransohoff Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications Hum Pathol 14 1983 931 968
6. DS Levine RC Haggitt PL Blount PS Rabinovitch VW Rusch BJ Reid An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus Gastroenterology 105 1993 40 50
7. BF Overholt M Panjehpour Photodynamic therapy for Barrett's esophagus Gastrointest Endosc Clin N Am 7 2 1997 207 220
8. DS Levine Barrett's oesophagus and p53 Lancet 344 1994 212 213
9. BJ Reid PL Blount CE Rubin DS Levine RC Haggitt PS Rabinovitch Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort Gastroenterology 102 1992 1212 1219
10. MB Fennerty RE Sampliner Flow cytometry in Barrett's esophagus: when all is said and done, more is said than done! Am J Gastroenterol 88 1993 319 320
11. RC Fitzgerald G Triadafilopoulos Recent developments in the molecular characterization of Barrett's esophagus Dig Dis 16 2 1998 63 80
12. MC Palanca-Wessels MT Barrett PC Galipeau KL Rohrer BJ Reid PS Rabinovitch Genetic analysis of long-term Barrett's esophagus epithelial cultures exhibiting cytogenetic and ploidy abnormalities Gastroenterology 114 2 1998 295 304
13. PC Galipeau DS Cowan CA Sanchez 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus Proc Natl Acad Sci U S A 93 14 1996 7081 7084
14. HM Cawley SJ Meltzer V DeBenedetti Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis Gastroenterology 115 1 1998 19 27
15. JH Peters GW Clark AP Ireland P Chandrasoma TC Smyrk TR DeMeester Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients J Thorac Cardiovasc Surg 108 1994 813 821
16. FHJ Ellis GJ Heatley MJ Krasna WA Williamson K Balogh Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria J Thorac Cardiovasc Surg 113 5 1997 836 846
17. WM Weinstein AF Ippoliti The diagnosis of Barrett's esophagus: goblets, goblets, goblets [editorial] Gastrointest Endosc 44 1 1996 91 95
18. EA Montgomery DP Hartmann NJ Carr DA Holterman LH Sobin N Azumi Barrett esophagus with dysplasia - flow cytometric DNA analysis of routine, paraffin-embedded mucosal biopsies Am J Clin Pathol 106 3 1996 298 304